greeksoup/ stock research
Stock research / United States / LGND / Planned sales

Ligand Pharmaceuticals Inc. planned insider sales

In the twelve months since 11 October 2025 insiders at Ligand Pharmaceuticals Inc. filed 28 Form 144 notices of planned sales, 147,169 shares worth $37.0 million at the time of filing, from 11 sellers. The latest, filed 10 September 2026: Martine Zimmermann (director), 1,200 shares worth $342,000, planned for around 10 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
10 September 2026Martine ZimmermannDirector1,200$342,00010 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
3 September 2026Andrew ReardonOfficer15,000$4.3 million3 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock Options; Performance Stock Units; Restricted Stock UnitsForm 144
12 August 2026Jason HaasDirector7,138$2.1 million12 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock; Stock Option ExerciseForm 144
12 August 2026Octavio EspinozaOfficer31,641$9.1 million12 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
1 July 2026Andrew ReardonOfficer10,000$3.2 million1 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
16 June 2026Stephen L. SabbaDirector2,145$544,83016 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
12 June 2026Jason HaasDirector6,461$1.7 million12 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock; Stock Option ExerciseForm 144
11 June 2026Aryeh JasonDirector4,500$1.1 million11 June 2026Wells Fargo Clearing ServicesOpen Market PurchaseForm 144
10 June 2026Aryeh JasonDirector500$124,98010 June 2026Wells Fargo Clearing ServicesOpen Market PurchaseForm 144
10 June 2026John L LamattinaDirector4,519$1.1 million10 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
10 June 2026Aryeh JasonDirector5,000$1.2 million10 June 2026Charles Schwab & Co., Inc.Open Market PurchasesForm 144
13 May 2026John KozarichDirector1,575$352,01213 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
12 May 2026John KozarichDirector459$102,81612 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
1 May 2026Kozarich John WDirector467$107,3491 May 2026UBS Financial Services, Inc.VariousForm 144
1 April 2026Kozarich John WDirector467$95,0341 April 2026UBS Financial Services, Inc.VariousForm 144
23 March 2026Stephen L. SabbaDirector1,000$207,87323 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercised SharesForm 144
11 March 2026Octavio EspinozaOfficer3,057$648,97111 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock Options; Previously Exercised Stock OptionsForm 144
6 March 2026John L LamattinaDirector2,161$433,8426 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
4 March 2026Octavio EspinozaOfficer13,423$2.7 million4 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock Options; Restricted & Performance Stock UnitsForm 144
4 March 2026Andrew ReardonOfficer20,000$4.1 million4 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
3 March 2026Stephen L. SabbaDirector2,034$409,8513 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
2 February 2026Kozarich John WDirector467$89,7482 February 2026UBS Financial Services, Inc.VariousForm 144
2 January 2026Kozarich John WDirector467$88,0762 January 2026UBS Financial Services, Inc.VariousForm 144
12 December 2025Octavio EspinozaOfficer1,804$339,71112 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
1 December 2025Kozarich John WDirector467$93,3441 December 2025UBS Financial Services, Inc.VariousForm 144
7 November 2025John L LamattinaDirector4,179$858,5767 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
7 November 2025Nancy GrayDirector6,571$1.4 million7 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
3 November 2025Kozarich John WDirector467$89,2193 November 2025UBS Financial Services, Inc.VariousForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for Ligand Pharmaceuticals Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install